🇨🇭 Switzerland Country × Condition
liver cirrhosis Clinical Trials in Switzerland
Active clinical trials for liver cirrhosis with research sites in Switzerland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇭 Switzerland
Active Trials in Switzerland (2)
NCT05869591 Phase 2
Recruiting
DOAC in Patients with Child a or B Liver Cirrhosis
Enrollment
40 pts
Country
🇨🇭 Switzerland
Centre Hospitalier Universitaire Va...
View Trial → NCT04874428 Phase 1
Recruiting
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
Enrollment
24 pts
Country
🇨🇭 Switzerland
Insel Gruppe AG, University Hospita...
View Trial → Frequently Asked Questions
How many liver cirrhosis clinical trials are active in Switzerland?
There are currently 2 active clinical trials for liver cirrhosis with sites in Switzerland, of which 2 are actively recruiting patients.
How can I join a liver cirrhosis clinical trial in Switzerland?
To join a liver cirrhosis clinical trial in Switzerland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Switzerland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are liver cirrhosis trials in Switzerland?
Active liver cirrhosis trials in Switzerland span Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology